期刊文献+

药物洗脱支架与冠状动脉旁路移植术治疗无保护左主干病变的疗效比较 被引量:2

下载PDF
导出
摘要 冠状动脉旁路移植术一直是无保护左主干病变的标准治疗手段。随着药物洗脱支架的出现,经皮冠状动脉介入治疗越来越多地应用于无保护左主干病变的治疗。比较与冠状动脉旁路移植术孰优孰劣,大量的研究已经证明应用药物洗脱支架治疗无保护左主干病变的安全性及有效性。药物洗脱支架介入治疗的适应证在进一步拓宽,介入治疗指南在不断更新,但就目前而言,无保护左主干病变的药物洗脱支架治疗由于其自身不足,尚不能完全替代冠状动脉旁路移植术。
出处 《国际心血管病杂志》 2013年第1期31-33,共3页 International Journal of Cardiovascular Disease
  • 相关文献

参考文献17

  • 1Lee MS,Kapoor N,Jamal F. Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease[J].Journal of the American College of Cardiology,2006,(04):864-870.
  • 2Chieffo A,Morici N,Maisano F. Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis:a single center experiencer[J].Circulation,2006,(21):2542-2547.
  • 3Chieffo A,Magni V,Latib A. 5-year outcomes following percutaneous coronary intervention with drug eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions (The Milan Experience)[J].JACC Cardiovasc Interv,2010,(06):595-601.
  • 4杨向军;过谨.药物洗脱支架和冠状动脉旁路移植术治疗无保护左主干病变的疗效分析[A],2011.
  • 5Seung KB,Park DW,Kim YH. Stents versus coronaryartery bypass grafting for left main coronary artery disease[J].New England Journal of Medicine,2008,(17):1781-1792.
  • 6Seung KB,Park DW,Kim YH. Long term safety and ef? cacy of stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease (5-Year Results From the MAIN-COMPARE Registry)[J].Journal of the American College of Cardiology,2010,(02):117-124.
  • 7Kang SH,Park KH,Choi DJ. Coronary artery bypass grafting versus drug-eluting stent implantation for left main coronary artery disease (from a two-center registry)[J].Journal of the American College of Cardiology,2010,(03):343-351.
  • 8Buszman PE,Buszman PP,Kiesz RS. Early and longterm results of unprotected left main coronary artery stenting:the LEMANS (Left Main Coronary Artery Stenting) registry[J].Journal of the American College of Cardiology,2009,(16):1500-1511.
  • 9Serruys PW,Morice MC,Kappetein AP. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease[J].New England Journal of Medicine,2009,(10):961-972.
  • 10Kappetein AP. SYNTAX:Optimal revascularization strategy in patients with three-vessel disease and/or left main disease:The 2 year outcomes of the SYNTAX Trial[R].Presentation at ESC,2009.

二级参考文献20

  • 1Chikwe J, Kim M, Goldstone AB, et al. Current diagnosis and management of left main coronary disease. Eur J Cardiothorac Surg,2010,38:420-428.
  • 2Sianos G, Morel MA, Kappetein AP, et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. Euro Intervention, 2005, 1:219-227.
  • 3Kim YH, Park DW, Kim WJ, et al. Impact of the extent of coronary artery disease on outcomes after revascularization for unprotected left main coronary artery stenosis. J Am Coil Cardiol, 2010, 55:2544-2552.
  • 4Celik T, Iyisoy A. The emerging role of percutaneous coronary intervention in the management of unprotected left main coronary artery disease: ongoing debate. Int J Cardiol, 2010, 144:90-91.
  • 5Lee MS, Bokhoor P, Park SJ, et al. Unprotected left main coronary disease and ST-segment elevation myocardial infarction: a contemporary review and argument for percutaneous coronary intervention. JACC Cardiovasc Interv, 2010, 3: 791-795.
  • 6Takagi H, Manabe H, Umemoto T. Percutaneous stenting versus bypass surgery for unprotected left main coronary artery disease. Am J Cardiol, 2010, 106: 1059.
  • 7Park DW, Kim YH, Song HG, et al. Long-term comparison of drug-eluting stents and coronary artery bypass grafting for muhivessel coronary revascularization 5-year outcomes from the as an medical center-muhivessel revaseularization registry. J Am Coil Cardiol, 2011, 57:128-137.
  • 8Chieffo A, Seung J, Park MD, et al. Favorable long-term outcome after drug-eluting stent implantation in nonbifureation lesions that involve unprotected left main coronary artery. Circulation, 2007, 116:158-162.
  • 9American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update ) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update ): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation, 2009, 120:2271-2306.
  • 10Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass graftiong for severe coronary artery disease. N Engl J Med, 2009,360 .. 961 - 972.

共引文献16

同被引文献18

  • 1Gilles Montalescot,Udo Sechtem,Stephan Achenbach,Felicita Andreotti,Chris Arden,Andrzej Budaj,Raffaele Bugiardini,Filippo Crea,Thomas Cuisset,Carlo Di Mario,J. Rafael Ferreira,Bernard J. Gersh,Anselm K. Gitt,Jean-Sebastien Hulot,Nikolaus Marx,Lionel H. Opie,Matthias Pfisterer,Eva Prescott,Frank Ruschitzka,Manel Sabaté,Roxy Senior,David Paul Taggart,Ernst E. van der Wall,Christiaan J.M. Vrints,Jose Luis Zamorano,Stephan Achenbach,Helmut Baumgartner,Jeroen J. Bax,Héctor Bueno,Vero.2013 ESC guidelines on the management of stable coronary artery disease[J]. European Heart Journal . 2013 (38)
  • 2Michael S. Lee,Pooya Bokhoor,Seung-Jung Park,Young-Hak Kim,Gregg W. Stone,Imad Sheiban,Giuseppe Biondi-Zoccai,Dario Sillano,Jonathan Tobis,David E. Kandzari.??Unprotected Left Main Coronary Disease and ST-Segment Elevation Myocardial Infarction(J)JACC: Cardiovascular Interventions . 2010 (8)
  • 3Joanna Chikwe,Michael Kim,Andrew B. Goldstone,Arzhang Fallahi,Thanos Athanasiou.??Current diagnosis and management of left main coronary disease(J)European Journal of Cardio-Thoracic Surgery . 2010 (4)
  • 4Coronary Aneurysms After Drug-Eluting Stent Implantation(J)Journal of the American College of Cardiology . 2009 (22)
  • 5Marie-Claude Morice,Patrick W. Serruys,A. Pieter Kappetein,Ted E. Feldman,Elisabeth St?hle,Antonio Colombo,Michael J. Mack,David R. Holmes,James W. Choi,Witold Ruzyllo,Grzegorz Religa,Jian Huang,Kristine Roy,Keith D. Dawkins,Friedrich Mohr.??Five-Year Outcomes in Patients With Left Main Disease Treated With Either Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting in the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery Trial(J)Circulation . 2014 (23)
  • 6Turgay Celik,Atila Iyisoy.??The emerging role of percutaneous coronary intervention in the management of unprotected left main coronary artery disease: Ongoing debate(J)International Journal of Cardiology . 2008 (1)
  • 7Shuai Zheng,Zhe Zheng,Jianfeng Hou,Shengshou Hu.Comparison between Drug-Eluting Stents and Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Disease: A Meta-Analysis of Two Randomized Trials and Thirteen Observational Studies. Cardiology . 2011
  • 8Gaku Nakazawa,Aloke V. Finn,Marc Vorpahl,Elena Ladich,Robert Kutys,Isidora Balazs,Frank D. Kolodgie,Renu Virmani.??Incidence and Predictors of Drug-Eluting Stent Fracture in Human Coronary Artery(J)Journal of the American College of Cardiology . 2009 (21)
  • 9Epstein Andrew J,Polsky Daniel,Yang Feifei,Yang Lin,Groeneveld Peter W.Coronary revascularization trends in the United States, 2001-2008. JAMA : the journal of the American Medical Association . 2011
  • 10Joanna J. Wykrzykowska,Scot Garg,Yoshinobu Onuma.Implantation of the biodegradable polymer biolimus-eluting stent in patients with high SYNTAX score is associated with decreased cardiac mortality compared to a permanent polymer sirolimus-eluting stent: two year follow-up results from the 'all-comers' LE. EUROINTERVENTION . 2011

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部